Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolysis in acute MI: recent randomized trials.

B Pitt1

  • 1Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.

Hospital Practice (Office Ed.)
|August 1, 1989
PubMed
Summary

Intravenous thrombolysis significantly benefits eligible patients by improving heart function and reducing mortality. Large trials confirm these positive outcomes, highlighting its therapeutic value.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Closing the Digitalis Divide: Back to the Basics of Randomized Controlled Trials.

Cardiovascular drugs and therapy·2021
Same author

Depressive symptoms and hazardous/harmful alcohol use are prevalent and correlate with stigma among TB-HIV patients in Lesotho.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author

Pulmonary tuberculosis diagnostic practices among people living with the human immunodeficiency virus in Lesotho.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author

Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction.

Clinical pharmacology and therapeutics·2017
Same author

Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.

International journal of cardiology·2017
Same author

Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease.

Clinical kidney journal·2015

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Intravenous thrombolysis is a critical treatment for acute cardiovascular events.
  • Assessing the efficacy of thrombolytic therapy is essential for patient outcomes.

Purpose of the Study:

  • To review large-scale clinical trials on intravenous thrombolysis.
  • To evaluate the benefits of thrombolysis in eligible patient populations.

Main Methods:

  • Systematic review of major clinical trials.
  • Analysis of reported patient outcomes including mortality and cardiac function.

Main Results:

  • All reviewed trials demonstrated significant benefits.
  • Key improvements include enhanced ventricular function.
  • Reduced mortality rates were observed in multiple studies.

Conclusions:

  • Intravenous thrombolysis offers substantial advantages for eligible patients.
  • The therapy effectively improves cardiac function and survival rates.
  • Evidence supports the continued use of thrombolysis in appropriate clinical settings.

Related Experiment Videos